 |
市场调查报告书
商品编码
1391930
狂犬病抗血清市场：按类型、按应用、按配销通路、按地区Rabies Antiserum Market, By Type (Monoclonal Antibodies, Polyclonal Antibodies), By Application (Pre-Exposure Prophylaxis, Post-Exposure Prophylaxis ), By Distribution Channel, By Geography |
||||||
2023年全球狂犬病抗血清市场规模将达12.4亿美元。预计2023年至2030年该市场将以3.3%的复合年增长率成长，到年终市场规模将达到15.6亿美元。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2022年 | 2023年市场规模 | 12.4亿美元 |
| 实绩资料 | 2018-2021 | 预测期 | 2023-2030 |
| 预测期复合年增长率 | 3.30% | 2030年市场规模预测 | 15.6亿美元 |
狂犬病抗血清用于保护接触可能患有狂犬病的动物的人。狂犬病是一种严重且几乎总是致命的疾病，透过被感染动物的唾液咬伤和抓伤传播给人类和其他动物。狂犬病是一种严重的疾病，可以透过被咬伤或抓伤（吐口水）的受感染动物的唾液传播给人类和其他动物。建议前往高风险地区的旅客接种一系列暴露前狂犬病疫苗和暴露后预防 (PEP)，以防被感染动物咬伤或抓伤。狂犬病免疫球蛋白有两种：人类狂犬病免疫球蛋白（HRIG）和马狂犬病免疫球蛋白（ERIG）。如果有的话，HRIG 是首选，但如果没有，ERIG 可以有效中和狂犬病病毒。
市场动态：
狂犬病预防的需求和狗咬伤发生率的上升预计将支持狂犬病抗血清市场的成长。此外，狂犬病疫苗接种意识的提高预计也将推动市场成长。此外，技术进步和消费行为的变化也是预测期内推动市场成长的主要因素。
另一方面，缺乏对先进技术的认识预计将限制市场成长。政府公共卫生机构和国际组织的认知配合措施有限也限制了市场的成长。据世界卫生组织称，2021 年，超过 109 个国家报告了人类和动物狂犬病病例。然而，国家监测系统薄弱，许多贫穷国家无法可靠地记录真实的发病率。由于准确的流行病学资料尚未公开，狂犬病造成的真正威胁往往被低估。这对调动政策关注和扩大狂犬病预防计画所需的资源（包括抗血清等生技药品的供应）构成了重大障碍。
本研究的主要特点
- 本报告详细分析了全球狂犬病抗血清市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
- 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
- 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
- 该报告根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球狂犬病抗血清市场的主要企业。
- 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出资讯的决策。
- 全球狂犬病抗血清市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
- 透过用于分析全球狂犬病抗血清市场的各种策略矩阵，将促进相关人员的决策。
目录
第一章 研究目的与假设
- 研究目标
- 假设
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规及趋势分析
- 市场动态
- 促进因素
- 狗咬伤事件增加
- 提高狂犬病疫苗接种意识
- 抑制因素
- 缺乏先进技术意识
- 机会
- 政府支持配合措施
- 影响分析
- 主要亮点
- 监管场景
- 产品发布/核准
- PEST分析
- 波特的分析
- 併购场景
第四章狂犬病抗血清市场－冠状病毒（COVID-19）大流行的影响
- 新型冠状病毒感染疾病（COVID-19）的流行病学
- 供需面分析
- 经济影响
第五章狂犬病抗血清市场，依类型，2018-2030
- 介绍
- 单株抗体（mAb）
- 多克隆抗体
第六章狂犬病抗血清市场，依应用分类，2018-2030
- 介绍
- 暴露前预防 (PrEP)
- 暴露后预防 (PEP)
第7章狂犬病抗血清市场，依配销通路，2018-2030
- 介绍
- 医院药房
- 零售药房
- 线上药房
第八章狂犬病抗血清市场，依地区，2018-2030
- 介绍
- 北美洲
- 美国
- 加拿大
- 欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 欧洲其他地区
- 亚太地区
- 中国
- 印度
- 日本
- 东南亚国协
- 澳洲
- 韩国
- 其他亚太地区
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 北非
- 中部非洲
- 南非
第9章竞争形势
- CSL Behring
- Sanofi Pasteur
- Grifols SA
- Bharat Serum and Vaccines Ltd.
- Novartis AG
- Kedrion Biopharma Inc.
- Biogenesis Bago SA
- Serum Institute of India Ltd.
- Haffkine Bio-Pharmaceutical Corporation Ltd.
- Shanghai Institute of Biological Products Co. Ltd.
- CNBG（China National Biotec Group）Co. Ltd.
- Harbin Pharmaceutical Group Co. Ltd.
- Beijing Tiantan Biological Products Co. Ltd.
第10章
- 调查方法
- 关于出版商
The global rabies antiserum market size was valued at USD 1.24 billion in 2023. The market is projected to grow at a CAGR of 3.3% from 2023 to 2030, resulting in an estimated market size of USD 1.56 billion by the end of 2030.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 1.24 Bn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 3.30% | 2030 Value Projection: | US$ 1.56 Bn |
Rabies antiserum is used to protect people who have been exposed to a potentially rabid animal. Rabies is a serious, almost always fatal disease that spreads from the saliva (spit) of an infected animal through a bite or scratch to humans and other animals. It can be prevented by getting immediate medical care and immunizations after the exposure. It is recommended that travelers to high-risk areas have a pre-exposure rabies vaccine series and be prepared with post-exposure prophylaxis (PEP) in case they are bitten or scratched by an infected animal. There are two types of rabies immunoglobulin available: human rabies immunoglobulin (HRIG) and equine rabies immunoglobulin (ERIG). HRIG is preferable when it is available, but if it is not, ERIG will be effective in neutralizing the rabies virus.
Market Dynamics:
The need to prevent rabies and the rising incidence of dog bites are expected to support growth of the rabies antiserum market. Additionally, the growing awareness regarding rabies vaccinations is also expected to propel growth of the market. Moreover, technological advancements and changing consumer behavior are other major factors expected to drive growth of the market over the forecast period.
On the other hand, a lack of awareness regarding advanced technology is expected to restrict market growth. Limited efforts by government public health agencies and international organizations towards awareness-generation activities have also restricted market growth. According to the WHO, in 2021, over 109 countries reported rabies cases in both humans and animals. But national surveillance systems were weak to reliably record the true incidence in many poorer nations. Without accurate epidemiological data available in the public domain, the real threat posed by rabies tends to get underestimated. This acts as a major roadblock in mobilizing necessary policy attention and resources for expanding rabies prevention programs, including the supply of biologics like antiserum.
Key features of the study:
- This report provides in-depth analysis of the global rabies antiserum market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global rabies antiserum market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include CSL Behring, Sanofi Pasteur, Grifols S.A., Bharat Serum and Vaccines Ltd., Novartis AG, Kedrion Biopharma Inc., Biogenesis Bago SA, MassBiologics, Serum Institute of India Ltd., Green Cross Corp., Haffkine, Bio-Pharmaceutical Corporation Ltd., Shanghai Institute of Biological Products Co. Ltd., CNBG (China National Biotec Group) Co. Ltd., Harbin Pharmaceutical Group Co. Ltd., and Beijing Tiantan Biological Products Co. Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global rabies antiserum market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rabies antiserum market
Detailed Segmentation:
- Rabies Antiserum Market, By Type
- Monoclonal Antibodies (mAbs)
- Polyclonal Antibodies
- Rabies Antiserum Market, By Application
- Pre-Exposure Prophylaxis (PrEP)
- Post-Exposure Prophylaxis (PEP)
- Rabies Antiserum Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Rabies Antiserum Market, By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Key Players
- CSL Behring
- Sanofi Pasteur
- Grifols S.A.
- Bharat Serum and Vaccines Ltd.
- Novartis AG
- Kedrion Biopharma Inc.
- Biogenesis Bago SA
- Serum Institute of India Ltd.
- Haffkine Bio-Pharmaceutical Corporation Ltd.
- Shanghai Institute of Biological Products Co. Ltd.
- CNBG (China National Biotec Group) Co. Ltd.
- Harbin Pharmaceutical Group Co. Ltd.
- Beijing Tiantan Biological Products Co. Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Rabies Antiserum, By Type
- Market Rabies Antiserum, By Application
- Market Rabies Antiserum, By Distribution Channel
- Market Rabies Antiserum, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Rising incidence of dog bites
- Growing awareness regarding rabies vaccinations
- Restraints
- Lack of awareness regarding advanced technologies
- Opportunities
- Supportive government initiatives
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Rabies Antiserum Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Rabies Antiserum Market , By Type, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
- Monoclonal Antibodies (mAbs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
- Polyclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
6. Rabies Antiserum Market , By Application, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
- Pre-Exposure Prophylaxis (PrEP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
- Post-Exposure Prophylaxis (PEP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
7. Rabies Antiserum Market , By Distribution Channel, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
8. Rabies Antiserum Market , By Region, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2023 -2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030, (US$ Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- CSL Behring
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi Pasteur
- Grifols S.A
- Bharat Serum and Vaccines Ltd.
- Novartis AG
- Kedrion Biopharma Inc.
- Biogenesis Bago SA
- Serum Institute of India Ltd.
- Haffkine Bio-Pharmaceutical Corporation Ltd.
- Shanghai Institute of Biological Products Co. Ltd.
- CNBG (China National Biotec Group) Co. Ltd.
- Harbin Pharmaceutical Group Co. Ltd.
- Beijing Tiantan Biological Products Co. Ltd.
- Analyst Views
10. Section
- Research Methodology
- About us
